5761 - 5770 of 6230 Results
Title
Year
-
OPENTitle: State-of-the-art pharmacological approaches to reduce chorea in Huntington’s diseaseJournal Name: Expert Opinion on PharmacotherapyPublisher: Informa UK LimitedVol: 22Issue #: 8Start Page: 1015End Page: 1024Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/14656566.2021.1876666Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8222076Citation Count: 22
-
OPENTitle: The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemicsJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 6Start Page: 615End Page: 623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1923480Best OA location URL: http://hdl.handle.net/11577/3395097Citation Count: 16
-
OPENTitle: Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosisJournal Name: Expert Review of ProteomicsPublisher: Informa UK LimitedVol: 18Issue #: 11Start Page: 977End Page: 994Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/14789450.2021.2004890Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14789450.2021.2004890?needAccess=trueCitation Count: 7
-
OPENTitle: Identification of risk factors for impulse-control disorder symptoms in patients with Parkinson’s diseaseJournal Name: Journal of Physics: Conference SeriesPublisher: IOP PublishingVol: 1722Issue #: 1Start Page: 012099End Page: 012099Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012099Best OA location URL: https://iopscience.iop.org/article/10.1088/1742-6596/1722/1/012099/pdfCitation Count: 1
-
OPENTitle: An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson’s DiseaseJournal Name: Journal of Clinical and Experimental NeuropsychologyPublisher: Informa UK LimitedVol: 43Issue #: 9Start Page: 918End Page: 925Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/13803395.2022.2034753Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8881345Citation Count: 4
-
OPENTitle: Rapid motor progression of Parkinson’s disease associates with clinical and genetic variantsJournal Name: Frontiers in Bioscience-LandmarkPublisher: IMR PressVol: 26Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.52586/5044Best OA location URL: https://www.imrpress.com/journal/FBL/26/12/10.52586/5044/pdfCitation Count: 9
-
OPENTitle: Analysis of factors associated with early stage Parkinson’s disease based on daily activities and sleeping behaviour disorderJournal Name: Journal of Physics: Conference SeriesPublisher: IOP PublishingVol: 1722Issue #: 1Start Page: 012045End Page: 012045Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012045Best OA location URL: https://iopscience.iop.org/article/10.1088/1742-6596/1722/1/012045/pdfCitation Count: 1
-
OPENTitle: Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer’s Disease or Dementia with Lewy BodiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 80Issue #: 4Start Page: 1603End Page: 1612Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-200323Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10109539Citation Count: 4
-
OPENTitle: Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 177End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202285?id=journal-of-parkinsons-disease%2Fjpd202285Citation Count: 49
-
OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 49